Remdesivir not recommended for hospitalized coronavirus patients, WHO says

Gilead’s drug remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilation, a … Read More

U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment

The United States has secured nearly the entire worldwide supply of remdesivir, a drug that’s proven effective for severely ill patients of the novel coronavirus — leaving hardly any for … Read More

Coronavirus drug remdesivir to cost $2,340 per patient in the U.S.

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government … Read More

Remdesivir, hailed as potential COVID-19 treatment, gets emergency U.S. FDA green light

Posted May 1, 2020 4:42 pm Smaller font Descrease article font size –A Larger font Increase article font size A+ Remdesivir has received emergency use authorization (EUA) from the U.S. … Read More

Experimental drug proven effective against coronavirus, biotech company says

A biotech company said Wednesday its experimental drug has proved effective against the new coronavirus in a major U.S. government study that put it to a strict test. Gilead Sciences’s … Read More

Coronavirus: Drug trial sees ‘encouraging’ results but researchers say more study needed

More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug, although there’s no way to know the odds of that happening without … Read More

Pinterest